This is a preview of subscription content, log in via an institution to check access.
Reference
Angulo JC, et al. Cost Effectiveness of Fesoterodine and Tolterodine for the Treatment of Overactive Bladder with Urge Urinary Incontinence in Spain and Finland. Clinical Drug Investigation : 25 Feb 2014. Available from: URL: http://dx.doi.org/10.1007/s40261-014-0178-1
Additional information
* The study was supported by Pfizer Ltd.
Rights and permissions
About this article
Cite this article
Fesoterodine cost effective in Spain, cost saving in Finland. PharmacoEcon Outcomes News 699, 6 (2014). https://doi.org/10.1007/s40274-014-1137-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1137-z